Skip to main content
Sirona Biochem Corp. logo

Sirona Biochem Corp. — Investor Relations & Filings

Ticker · SRBCF ISIN · CA82967M1005 LEI · 549300CQE1Q87IG6W210 TSXV Real estate activities
Open in API
Filings indexed 367 across all filing types
Latest filing 2023-10-26 Regulatory Filings
Country CA Canada
Listing TSXV SRBCF

About Sirona Biochem Corp.

https://www.sironabiochem.com/

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery firm utilizing a proprietary platform technology to develop novel compounds. Through its wholly-owned French subsidiary, TFChem, the company specializes in stabilizing carbohydrate molecules, often via fluorination chemistry, to enhance their efficacy and safety for medical and cosmetic applications. Sirona Biochem's business strategy involves licensing or selling its patented compounds, such as the anti-aging and anti-wrinkle molecule GlycoProteMim™ (TFC-1326), to leading global pharmaceutical and cosmetic companies in exchange for up-front fees, milestone payments, and ongoing royalties.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document announces a change of auditor for Sirona Biochem Corp., specifying the former and successor auditors, effective date, and compliance with National Instrument 51-102. It includes no financial statements or detailed audit reports but references filing a Change of Auditor Notice on SEDAR. The document length is 3590 characters, relatively short, and primarily serves as an announcement rather than containing the audit report itself. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about auditor change without the full audit report or financial data.
2023-10-26 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the payment of interest on convertible debentures through the issuance of common shares. It details the terms of the debentures, the number of shares to be issued, the price per share, and regulatory conditions including TSX Venture Exchange approval. There is no financial statement, comprehensive financial data, or detailed report content. The document is an update on a financing activity related to convertible debentures and share issuance as interest payment. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. The document length is under 5,000 characters and is a standalone announcement, not a report publication announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2023-10-20 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the Chief Financial Officer regarding the interim financial report and interim MD&A for the period ended July 31, 2023. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The content is primarily an officer certification attesting to the accuracy and fair presentation of the interim filings, without containing the actual financial data or analysis itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3023 characters), and it is clearly a certification letter rather than a full interim report.
2023-09-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CEO of Sirona Biochem Corp. regarding the review and fair presentation of the company's interim financial report and interim MD&A for the period ended July 31, 2023. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The document does not contain actual financial data or the interim report itself but is an officer certification related to the interim filings. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than the interim report (IR) itself.
2023-09-29 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis for the Nine Months Ended July 31, 2023' and contains detailed financial analysis, liquidity, capital resources, and operational results for the nine-month period ending July 31, 2023. It includes financial data, comparisons to prior periods, and forward-looking statements typical of an MD&A section. The document is about 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content is consistent with a comprehensive interim or quarterly report rather than a full annual report or other filing types. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-09-29 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS' for the nine months ended July 31, 2023. It contains detailed financial statements including statements of financial position, loss and comprehensive loss, changes in shareholders' equity, and cash flows. The notes to the financial statements discuss accounting policies, going concern, and other relevant disclosures. The document is unaudited and prepared by management, consistent with an interim or quarterly report. The length is about 15,000 characters, indicating a full report rather than a brief announcement. There is no indication that this is an annual report (10-K) or a full audit report (AR). The presence of detailed financial data for a period shorter than a full fiscal year (nine months) aligns with the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-09-29 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.